Feed items
Analysis: What Will Cause Janet Yellen to Finally Raise Rates?
(Bloomberg) -- The effectiveness of the Federal Reserve’s communication strategy is clearly questionable when the outcome of a Federal Open Market Committee...
Millions of Boomers Are Making This Big Retirement Mistake
After several years of rising returns, 401(k) investors will be reminded with their next statements that investments in the stock market don’t always go up. The S&P 500 is down more than 8 percent over the past three months,...
Stocks set for higher open ahead of Yellen speech
U.S. stock index futures indicated a higher open on Thursday as traders looked to a speech on inflation and policy from Fed Chair Janet Yellen.
Mixed reaction seen in Asian stock markets
Asian shares traded mixed on Thursday, with Japan's Nikkei 225 index lagging on its first day of trade following a five-day long weekend.
Volkswagen may appoint new CEO by Friday
The leading candidates range from a decades-long veteran of VW to a pair of newcomers who have been with the company less than a year.
How smog cops busted Volkswagen
The revelation that ended Martin Winterkorn’s career at Volkswagen AG came on Sept. 3 in a meeting at an office park east of Los Angeles.
Volkswagen warned of emission glitch in April
Volkswagen of America, Inc. sent letters to California owners of diesel-powered Audis and Volkswagens informing them of an “emissions service action” affecting the vehicles.
Asian shares off to a cautious start on dour China news
Asian shares got off to a cautious start on Thursday after more dour economic news in China.
Oil holds below $45 as U.S. output climbs amid refiner slowdown
Oil held below $45 a barrel as U.S. production increased for the first time in seven weeks and as refiners cut operating rates by the most since January in the world’s biggest consumer.
Fury over drug price spikes rising, but increases aren't new
Hillary Clinton was among the patients and politicians who voiced outrage this week after it became public that the price of a 62-year-old drug used to treat a life-threatening infection had been raised by more than 5,000 percent.
Facebook
Become a fan
Twitter
Follow us
RSS
Subscribe